Wilms' tumor 1 as a novel target for immunotherapy of leukemia

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 3309-3311

  Casalegno Garduno R ^a   Schmitt, A ^a   Wang, X ^a   Xu, X ^a   Schmitt, M ^a  

^a Head Clinical Stem Cell Transplantation and Immunotherapy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA ANTIGEN;

ADOPTIVE TRANSFER; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DONOR LYMPHOCYTE INFUSION; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; LEUKEMIA; NEPHROBLASTOMA; PRIORITY JOURNAL; REVIEW;

EID: 77958594693     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.07.034     Document Type: Article

References (20)

1. J. Greiner, L. Bullinger, and B. Guinn Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells Clin Cancer Res 14 2008 7161
2. H. Miwa, M. Beran, and G.F. Saunders Expression of the Wilms' tumor gene (WT1) in human leukemias Leukemia 6 1992 405
3. D. Cilloni, F. Messa, and F. Arruga Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy Haematologica 93 2008 921
4. Y. Oka, A. Tsuboi, and T. Taguchi Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression Proc Natl Acad Sci USA 101 2004 13885
5. V. Mailander, C. Scheibenbogen, and E. Thiel Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity Leukemia 18 2004 165
6. X. Wang, A. Schmitt, and L. Germeroth Generation of leukemia antigen-specific donor lymphocyte infusions powered by streptamer-based selection Bone Marrow Transplant 43 2009 S73
7. J. Neudorfer, B. Schmidt, and K.M. Huster Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens J Immunol Methods 320 2007 119
8. H.J. Kolb Graft-versus-leukemia effects of transplantation and donor lymphocytes Blood 112 2008 4371
9. M. Cobbold, N. Khan, and B. Pourgheysari Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers J Exp Med 202 2005 379
10. + T cells leads to enduring virus clearance in patients after allogeneic stem cell transplantation 50th ASH Annual meeting Blood 112 2008 1181
11. L. Bergmann, D.K. Schui, and J. Brieger The inhibition of lymphokine-activated killer cells in acute myeloblastic leukemia is mediated by transforming growth factor-beta 1 Exp Hematol 23 1995 1574
12. U. Schulz, R. Munker, and B. Ertl Different types of human leukemias express the message for TNF-alpha and interleukin-10 Eur J Med Res 6 2001 359
13. G. Pawelec, A. Rehbein, and E. Schlotz Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro Cancer Immunol Immunother 42 1996 193
14. R.V. Goddard, A.G. Prentice, and J.A. Copplestone In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electro-fusion hybrids Clin Exp Immunol 131 2003 82
15. N. Hirano, T. Takahashi, and T. Takahashi Expression of costimulatory molecules in human leukemias Leukemia 10 1996 1168
16. S. Dermime, D. Mavroudis, and Y.Z. Jiang Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation Bone Marrow Transplant 19 1997 989
17. R.E. Brouwer, J. Hoefnagel, and B.B. Borger van Der Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis Br J Haematol 115 2001 298
18. S. Kamihira, Y. Yamada, and M. Tomonaga Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis Br J Haematol 107 1999 851
19. C. Schmid, M. Schleuning, and J. Aschan Low dose ara-c, donor cells and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation: a pilot study Leukemia 18 2004 1430
20. M. Ono, H. Yaguchi, and N. Ohkura Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 Nature 446 2007 685